Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
Ironwood Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 22, 2021
Ironwood Pharmaceuticals reported fiscal year 2020 executive compensation information on April 22, 2021.
In 2020, five executives at Ironwood Pharmaceuticals received on average a compensation package of $3.4M, a 38% decrease compared to previous year.
Average pay of disclosed executives at Ironwood Pharmaceuticals
Mark Mallon, Chief Executive Officer, received $6.8M in total, which decreased by 32% compared to 2019. 80% of Mallon's compensation, or $5.4M, was in stock awards. Mallon also received $585K in non-equity incentive plan, $801K in salary, as well as $11K in other compensation.
For fiscal year 2020, the median employee pay was $222,011 at Ironwood Pharmaceuticals. Therefore, the ratio of Mark Mallon's pay to the median employee pay was 31 to one.
Thomas A. McCourt, Chief Executive Officer, received a compensation package of $3.4M, which decreased by 33% compared to previous year. 72% of the compensation package, or $2.5M, was in stock awards.
Gina Consylman, Chief Financial Officer, earned $2.5M in 2020, a 29% decrease compared to previous year.
Jason Rickard, Chief Operating Officer, received $2.2M in 2020.
Michael Shetzline, Chief Medical Officer, earned $1.9M in 2020.
Related executives
Mark Mallon
Ironwood Pharmaceuticals
Chief Executive Officer
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 22, 2021.